Key Points
- COO John Gallagher sold 430 shares of Trupanion on March 30 at an average price of $25.47 for about $10,952, leaving him with 31,957 shares—a roughly 1.33% reduction in his stake (valued ≈ $813,945).
- Trupanion reported $0.13 EPS for the quarter (missing the $0.14 consensus) with revenue of $376.85M (+11.7% YoY); the stock trades near its 12‑month low ($24.32) with a market cap of about $1.11B and a P/E of ~57.
- Several hedge funds have increased positions in TRUP while analysts have trimmed ratings and targets, leaving a consensus rating of "Hold" and a $44.50 average price target.
Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) COO John Gallagher sold 430 shares of Trupanion stock in a transaction on Monday, March 30th. The stock was sold at an average price of $25.47, for a total value of $10,952.10. Following the transaction, the chief operating officer owned 31,957 shares in the company, valued at approximately $813,944.79. This represents a 1.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Trupanion Trading Up 0.8%
Shares of TRUP opened at $25.65 on Friday. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.27. Trupanion, Inc. has a 12-month low of $24.32 and a 12-month high of $57.88. The firm has a 50-day moving average price of $28.32 and a 200 day moving average price of $35.32. The firm has a market capitalization of $1.11 billion, a P/E ratio of 57.00 and a beta of 1.66.
Trupanion (NASDAQ:TRUP - Get Free Report) last issued its earnings results on Thursday, February 12th. The financial services provider reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.14 by ($0.01). The firm had revenue of $376.85 million for the quarter, compared to analysts' expectations of $375.89 million. Trupanion had a return on equity of 5.39% and a net margin of 1.35%.Trupanion's revenue for the quarter was up 11.7% on a year-over-year basis. During the same period last year, the firm earned $0.04 earnings per share. Sell-side analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current year.
Hedge Funds Weigh In On Trupanion
A number of hedge funds have recently made changes to their positions in TRUP. Royal Bank of Canada increased its holdings in Trupanion by 60.6% in the 1st quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider's stock valued at $1,109,000 after purchasing an additional 11,233 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Trupanion by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider's stock worth $731,000 after purchasing an additional 858 shares in the last quarter. Millennium Management LLC boosted its position in shares of Trupanion by 73.5% during the first quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider's stock worth $9,987,000 after buying an additional 113,490 shares during the period. Creative Planning boosted its position in shares of Trupanion by 55.3% during the second quarter. Creative Planning now owns 12,512 shares of the financial services provider's stock worth $693,000 after buying an additional 4,453 shares during the period. Finally, JPMorgan Chase & Co. grew its stake in shares of Trupanion by 66.7% in the second quarter. JPMorgan Chase & Co. now owns 161,781 shares of the financial services provider's stock valued at $8,955,000 after buying an additional 64,704 shares in the last quarter.
Analyst Ratings Changes
A number of research analysts recently commented on TRUP shares. Piper Sandler decreased their price objective on Trupanion from $60.00 to $45.00 and set an "overweight" rating on the stock in a report on Friday, February 13th. Zacks Research cut Trupanion from a "strong-buy" rating to a "hold" rating in a research note on Friday, February 13th. Cantor Fitzgerald reduced their target price on Trupanion from $50.00 to $42.00 and set a "neutral" rating on the stock in a research report on Wednesday, January 14th. Wall Street Zen cut Trupanion from a "buy" rating to a "hold" rating in a report on Saturday, December 6th. Finally, Stifel Nicolaus lowered their price target on Trupanion from $35.00 to $31.00 and set a "hold" rating for the company in a report on Tuesday. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $44.50.
Check Out Our Latest Analysis on TRUP
Trupanion Company Profile
(
Get Free Report)
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
